Sinapis Pharma
Jacksonville
About Sinapis Pharma
Sinapis Pharma, Inc, a drug development company, engages in the discovery and development of methamphetamine, an intravenous neuroprotective agent for the treatment of acute stroke and brain injury.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $821.2K
- Last round: Series Unknown (May 2010)
- Website: sinapispharma.com
- Phone: 9046190034
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/sinapis-pharma-2128586 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.